ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE
Clinical trials for ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE explained in plain language.
Never miss a new study
Get alerted when new ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE trials appear
Sign up with your email to follow new studies for ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which IV drug tames a racing heart in AFib faster? a Head-to-Head trial
Disease control Not yet recruitingThis trial compares two standard IV medicines—verapamil and metoprolol—to see which controls rapid heart rate better in adults with atrial fibrillation who are otherwise stable. Patients receive one of the drugs in the emergency department, and their heart rate, blood pressure, a…
Matched conditions: ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE
Phase: PHASE4 • Sponsor: Muhammad Ali Javed • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
AI reads Single-Lead ECG to predict AFib with rapid heart rate within two hours
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence software called SMD-RVECG can predict the risk of atrial fibrillation with rapid ventricular response (a fast, irregular heart rhythm) within the next two hours. Researchers will analyze 348 existing single-lead electrocardiogra…
Matched conditions: ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE
Sponsor: HUINNO Co., Ltd • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Could a simple mineral tame a racing heart? new trial tests magnesium for AFib
Symptom relief Not yet recruitingThis study tests whether giving magnesium along with the standard drug metoprolol can quickly lower a dangerously fast heart rate in people with atrial fibrillation or atrial flutter. About 196 adults in the emergency room will receive either magnesium or a placebo, plus metoprol…
Matched conditions: ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC